InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: ClosetInvestor post# 148265

Tuesday, 02/23/2021 8:38:06 AM

Tuesday, February 23, 2021 8:38:06 AM

Post# of 233207

This is the first time in biotech/BP history that a company has submitted their data to the FDA (in this case, multiple FDAs) to ask for approval BEFORE announcing success of an endpoint. Look at the previous vaccines and MABs that have been approved for COVID: they announced efficacy first and then that they’d apply for EUA. If the primary endpoint had been met, CYDY would’ve PRed it.


Is it possible (and probable) they honored the FDA's request to send them the data as soon as it was unblinded and to not wait for the top line results?

Is it possible Nader did what he said he would do when he said during the last investor call that he would reveal the primary endpoint/mortality numbers in the full report, and not before then?

When did they receive the top line results? I must have missed that in the PR.

My comments are just my opinions and should NOT be taken as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News